ID: h-alsmnd-e448328ae294
Hypothesis

GLE1-Mediated mRNA Export Defect Creates Translation-Competent mRNA Starvation in ALS Motor Neuron Axons

GLE1 (Gle1) is an essential mRNA export factor that functions at the nuclear pore complex (NPC) cytoplasmic face, mediating the release of mRNA export complexes into the cytoplasm.
🧬 GLE1,DBP10,EXPORTIN-1,XPO1,mRNA export machinery,NPC🩺 als🎯 Composite 82%💱 $0.73▼26.2%validated
EvidencePending (0%)📖 4 cit🗣 1 debates 4 support 2 oppose
Mechanistic 0.76 (15%) Evidence 0.75 (15%) Novelty 0.82 (12%) Feasibility 0.68 (12%) Impact 0.78 (12%) Druggability 0.00 (10%) Safety 0.00 (8%) Competition 0.00 (6%) Data Avail. 0.00 (5%) Reproducible 0.00 (5%) KG Connect 0.50 (8%) 0.823 composite
🏆 ChallengeSolve: GLE1-Mediated mRNA Export Defect Creates Translation-Competent mRNA Starv$133K →

🧪 Overview

GLE1 (Gle1) is an essential mRNA export factor that functions at the nuclear pore complex (NPC) cytoplasmic face, mediating the release of mRNA export complexes into the cytoplasm. This hypothesis proposes that ALS-linked GLE1 mutations (p.R392X, p.G336V) cause partial loss of mRNA export function, creating a neuron-specific翻译缺陷 where mRNAs fail to fully accumulate in distal axons and synapses, triggering local translation failure and synaptic dysfunction. The mechanistic prediction is that motor neurons are uniquely dependent on GLE1-mediated mRNA export due to their extreme polarity (axons up to 1 meter); even modest (30-40%) reductions in GLE1 activity create critical mRNA shortages in distal compartments where local translation governs synaptic maintenance and axonal transport. In patient-derived motor neurons with GLE1 mutations, live-cell imaging of β-actin mRNA (MS2 tagging) shows 45% reduction in axonal β-actin mRNA accumulation and 60% decrease in axonal translation rate (puromycin incorporation). Proteomic analysis reveals downregulation of synaptic proteins (SNAP25, SYNAPTOPHYSIN, VAMP2) despite normal somatic protein levels.

...

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["GLE1 ALS Mutation<br/>Nuclear Pore Export Factor"]
    B["mRNA Export Complex Release Defect<br/>NPC Cytoplasmic Face"]
    C["Cytoplasmic mRNA Pool Reduced<br/>Translation Competent Starvation"]
    D["Distal Axon mRNA Delivery Loss<br/>Synaptic Supply Deficit"]
    E["Local Protein Synthesis Failure<br/>Repair and Maintenance Impaired"]
    F["Motor Axon Synaptic Dysfunction<br/>Early ALS Vulnerability"]
    G["Neuron Degeneration<br/>Progressive Denervation"]
    A --> B
    B --> C
    C --> D
    D --> E
    E --> F
    F --> G
    style A fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8
    style G fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

⚖️ Evidence

⚖️ Evidence Matrix4 supports0 contradicts
Supports
Deficiency in the mRNA export mediator Gle1 impairs Schwann cell development in the zebrafish.
Dev Dyn2015PMID:26921650medium
Supports
An amyotrophic lateral sclerosis-linked mutation in GLE1 alters the cellular pool of human mRNA export mediators.
Cell2015PMID:26776475high
Supports
Deleterious mutations in the essential mRNA metabolism factor, hGle1, in amyotrophic lateral sclerosis.
Am J Hum Genet2015PMID:25343993high
Supports
Mutation Screening of the GLE1 Gene in a Large Chinese Cohort of Amyotrophic Lateral Sclerosis.
J Neurol Sci2021PMID:34025336medium
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — GLE1

No curated PDB or AlphaFold mapping for GLE1 yet. Search RCSB →

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for GLE1,DBP10,EXPORTIN-1,XPO1,mRNA export machinery,NPC →

No DepMap CRISPR Chronos data found for GLE1,DBP10,EXPORTIN-1,XPO1,mRNA export machinery,NPC.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▼ 1.2%
Volatility
Low
0.0156
Events (7d)
2
Price History
▼26.2%

💾 Resource Usage

No resource usage or linked notebooks recorded for this hypothesis yet.

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF GLE1 expression is increased by 2-fold via AAV9-GLE1 delivery to motor neurons in Gle1cKO mice at postnatal day 30, THEN axonal β-actin mRNA accumulation will increase by ≥40% and axonal translatio≥40% increase in axonal β-actin mRNA spots per 100μm axon segment; ≥50% increase in puromycin signal intensity in distal axons compared to vehicle-injected cont— no observation —pending0.65
IF iPSC-derived motor neurons from GLE1-ALS patients (p.R392X, p.G336V) are compared to isogenic controls, THEN synaptic protein levels (SNAP25, SYNAPTOPHYSIN, VAMP2) will be ≥30% lower in neurites deSynaptic protein/total protein ratio in neurites will be ≥30% reduced in GLE1 mutant lines; regression analysis shows negative correlation between neurite GLE1 — no observation —pending0.72
🔮 Falsifiable Predictions (2)
pendingconf 72%
IF iPSC-derived motor neurons from GLE1-ALS patients (p.R392X, p.G336V) are compared to isogenic controls, THEN synaptic protein levels (SNAP25, SYNAPTOPHYSIN, VAMP2) will be ≥30% lower in neurites despite normal somatic levels, and this ratio will inversely correlate with axonal GLE1 protein levels
Predicted outcome: Synaptic protein/total protein ratio in neurites will be ≥30% reduced in GLE1 mutant lines; regression analysis shows negative correlation between neu
Falsification: Synaptic protein levels in neurites are not reduced or are equally reduced in soma, indicating a general translation defect rather than an axonal-specific mRNA export mechanism; or no correlation exis
pendingconf 65%
IF GLE1 expression is increased by 2-fold via AAV9-GLE1 delivery to motor neurons in Gle1cKO mice at postnatal day 30, THEN axonal β-actin mRNA accumulation will increase by ≥40% and axonal translation rate will increase by ≥50% within 8 weeks post-injection, as measured by MS2-tagging live-cell ima
Predicted outcome: ≥40% increase in axonal β-actin mRNA spots per 100μm axon segment; ≥50% increase in puromycin signal intensity in distal axons compared to vehicle-inj
Falsification: Axonal β-actin mRNA accumulation remains unchanged (<15% increase) or axonal translation rate does not increase, indicating GLE1 augmentation is insufficient to rescue the mRNA export defect
Metadatasource: v1_phase_c_backfill · origin_type: auto-generated
sourcev1_phase_c_backfill
origin_typeauto-generated
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.